{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T08:47:32Z","timestamp":1775638052789,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jvs.2025.03.183","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T18:38:58Z","timestamp":1742668738000},"page":"581-590.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Variations in antithrombotic prescriptions and evaluation of extended clopidogrel therapy after lower extremity revascularization for peripheral artery disease"],"prefix":"10.1016","volume":"82","author":[{"given":"Nicholas","family":"Wells","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Alameddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uday","family":"Dhanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6315-5435","authenticated-orcid":false,"given":"Lydia","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Slade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul J.","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0046-752X","authenticated-orcid":false,"given":"Cassius Iyad","family":"Ochoa Chaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2025.03.183_bib1","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.03.183_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ahj.2016.06.002","article-title":"Significant variation in P2Y12 inhibitor use after peripheral vascular intervention in Medicare beneficiaries","volume":"179","author":"Jones","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2025.03.183_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008791","article-title":"Discharge prescription patterns for antiplatelet therapy following lower extremity peripheral vascular intervention","volume":"13","author":"Singh","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2025.03.183_bib4","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.3390\/jcm11185455","article-title":"Antithrombotic treatment patterns of patients with symptomatic peripheral arterial occlusive disease in Germany: evidence from health Insurance Claims data","volume":"11","author":"Peters","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jvs.2025.03.183_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.avsg.2022.08.016","article-title":"Variability in antithrombotic therapy after infrainguinal lower extremity bypass","volume":"88","author":"Brahmandam","year":"2023","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2025.03.183_bib6","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ejvs.2024.05.034","article-title":"Patient factors influencing prescription of antithrombotic medication after lower limb endovascular intervention","volume":"68","author":"Zhu","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2025.03.183_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-081628","article-title":"Disparities in the real-world prescription pattern of oral anticoagulants for US Medicare beneficiaries: a geospatial analysis","volume":"14","author":"Zou","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.jvs.2025.03.183_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/ph15050596","article-title":"Mono or dual antiplatelet therapy for treating patients with peripheral artery disease after lower extremity revascularization: a systematic review and meta-analysis","volume":"15","author":"Tsai","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3 Suppl","key":"10.1016\/j.jvs.2025.03.183_bib9","doi-asserted-by":"crossref","first-page":"2s","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.03.183_bib10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1583\/13-4275MR.1","article-title":"Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease","volume":"20","author":"Strobl","year":"2013","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2025.03.183_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.jvs.2025.03.183_bib12","first-page":"2359","article-title":"Optimal strategy for antiplatelet therapy after endovascular revascularization for lower extremity peripheral artery disease","volume":"12","author":"Cho","year":"2019","journal-title":"JACC: Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2025.03.183_bib13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jvs.2010.04.027","article-title":"Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial","volume":"52","author":"Belch","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.03.183_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehn534","article-title":"Patients with peripheral arterial disease in the CHARISMA trial","volume":"30","author":"Cacoub","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2025.03.183_bib15","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","article-title":"Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial","volume":"49","author":"Bhatt Deepak","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2025.03.183_bib16","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s40265-022-01756-6","article-title":"Antithrombotic therapy for Symptomatic peripheral arterial disease: a systematic review and network meta-analysis","volume":"82","author":"Willems","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.jvs.2025.03.183_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135692","article-title":"Comparative Efficacy and Safety of different antiplatelet agents for prevention of major cardiovascular events and leg amputations in patients with peripheral arterial disease: a systematic review and network meta-analysis","volume":"10","author":"Katsanos","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jvs.2025.03.183_bib18","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca Marc","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jvs.2025.03.183_bib19","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jvs.2025.03.183_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2025.03.183_bib21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(99)07199-8","article-title":"Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trial","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2025.03.183_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa065959","article-title":"Oral anticoagulant and antiplatelet therapy and peripheral arterial disease","volume":"357","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jvs.2025.03.183_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.avsg.2024.04.005","article-title":"Following the COMPASS: antithrombotic prescription trends in patients with Symptomatic peripheral arterial disease following revascularization","volume":"106","author":"Elzawy","year":"2024","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2025.03.183_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041715","article-title":"Platelet aggregation inhibitor prescription for newly diagnosed peripheral arterial disease in The Netherlands: a cohort study","volume":"11","author":"Brand","year":"2021","journal-title":"BMJ Open"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521425006159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521425006159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T18:34:57Z","timestamp":1754073297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521425006159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0741521425006159"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2025.03.183","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variations in antithrombotic prescriptions and evaluation of extended clopidogrel therapy after lower extremity revascularization for peripheral artery disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2025.03.183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Vascular Surgery. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}